Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions
Status:
RECRUITING
Trial end date:
2027-01-30
Target enrollment:
Participant gender:
Summary
Investigating the Association Between Corticosteroid Use and Improvement in Doxorubicin Liposome-Induced Cutaneous Toxicity: Exploring the Feasibility and Mechanisms of Corticosteroids in Mitigating Liposomal Doxorubicin-Related Dermatologic Adverse Effects.